ClinicalTrials.Veeva

Menu

Local Triamcinolone Injection in Active Thyroid Orbitopathy

H

HaEmek Medical Center, Israel

Status

Unknown

Conditions

Thyroid Disease

Treatments

Drug: Triamcinolone

Study type

Interventional

Funder types

Other

Identifiers

NCT01280214
EMC119710ctil

Details and patient eligibility

About

Comparing the effectiveness of subconjunctival and peribulbar Triamcinolone injection to systemic Steroid therapy for patients with active thyroid orbitopathy.

Full description

Local Steroid treatment may help in active thyroid orbitopathy. till today, systemic Steroids are the treatment for active thyroid orbitopathy which is associated with systemic adverse effects.

In this study the investigators want to compare the effectiveness of local Triamcinolone therapy for active thyroid orbitopathy.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>18 years.
  • Active thyroid orbitopathy according to clinical activity score>=3.

Exclusion criteria

  • Intraorbital or active infections.
  • Tuberculosis.
  • Other orbital disease.
  • Pregnancy.
  • Compressive optic neuropathy.
  • Systemic steroid therapy within 6 months of study start.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Triamcinolone
Experimental group
Treatment:
Drug: Triamcinolone

Trial contacts and locations

0

Loading...

Central trial contact

Daniel Briscoe, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems